ArticleDiabetology & metabolic syndrome2025
Comparative analysis of insulin resistance indicators in predicting reversion from prediabetes to normoglycemia.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association of the CUN-BAE index with glycemic outcomes in individuals with impaired fasting glucose: a retrospective multicenter Chinese cohort study.Frontiers in nutrition · 2026Article
- A predictive study of glycaemic reversal in Chinese individuals with prediabetes based on machine learning: a 5-year cohort study.Frontiers in endocrinology · 2026Article
- Diagnostic Performance of Surrogate Indices of Insulin Resistance Compared with HOMA2-IR in Non-Diabetic Patients with Acute Coronary Syndrome.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndicators for insulin resistance (IR) have been proposed for predicting dysglycemia; however, their comparative effectiveness in predicting reversion from prediabetes to normoglycemia remains unclear. This study aimed to compare the predictive performance of four IR indicators for normoglycemia reversion in Chinese adults with prediabetes.
methodsThis retrospective cohort study included 15,415 participants with prediabetes-fasting plasma glucose (FPG) levels of 5.6-6.9 mmol/L. Normoglycemia reversion was defined as FPG levels < 5.6 mmol/L without a diabetes diagnosis at follow-up. Baseline metabolic scores for IR (MetS-IR), triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio were calculated. Cox proportional hazards models assessed associations between IR indicators and normoglycemia reversion. C-statistics, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were calculated to assess the predictive ability of IR indicators in addition to a base model.
resultsOver 3.2 years, 6,624 (43.0%) participants reverted to normoglycemia. After adjusting for potential confounders, a one-standard-deviation increase in MetS-IR, TyG, TyG-BMI, and TG/HDL-C was significantly associated with a lower likelihood of normoglycemia reversion (hazard ratios [95% confidence interval {CI}]: 0.79 [0.77, 0.82], 0.89 [0.87, 0.91], 0.84 [0.82, 0.86], and 0.88 [0.85, 0.90], respectively). The base model showed modest discrimination (C-statistic: 0.608). Adding MetS-IR improved C-statistics most (+ 0.018), followed by TyG-BMI (+ 0.009), TG/HDL-C (+ 0.008), and TyG (+ 0.006). MetS-IR significantly improved NRI (0.109, 95% CI 0.071-0.172) and IDI (0.016, 95% CI 0.009-0.025).
conclusionsMetS-IR appears to be a more effective predictor of normoglycemia reversion compared to other IR indicators, potentially aiding in the early identification of individuals with prediabetes likely to achieve spontaneous reversion, thereby supporting personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.